These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18985450)

  • 1. Octreotide uptake in intracranial metastasis of pancreatic ductal adenocarcinoma origin in a patient with a prolonged clinical course.
    Marepaily R; Micheals D; Sloan A; Hatfield J; Adsay V; Joyrich R; Ullah N; Tobi M
    Dig Dis Sci; 2009 Jan; 54(1):188-90. PubMed ID: 18985450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [111-indium DTPA octreotide scintigraphy in colorectal liver metastases].
    Seifert JK; Görges R; Bockisch A; Junginger T
    Langenbecks Arch Chir; 1997; 382(6):332-6. PubMed ID: 9498205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
    Vezzosi D; Bennet A; Rochaix P; Courbon F; Selves J; Pradere B; Buscail L; Susini C; Caron P
    Eur J Endocrinol; 2005 May; 152(5):757-67. PubMed ID: 15879362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of octreotide in the regression of a metastatic carcinoid tumour despite negative imaging with In-111-pentetreotide (Octreoscan).
    Hillman N; Herranz L; Alvarez C; Martínez Olmos MA; Márco A; Gómez-Pan A
    Exp Clin Endocrinol Diabetes; 1998; 106(3):226-30. PubMed ID: 9710364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cancer: does octreotide offer any promise?
    Rosenberg L
    Chemotherapy; 2001; 47 Suppl 2():134-49. PubMed ID: 11275707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Somatostatin receptors--new diagnostic and therapeutic possibilities].
    Pawlikowski M
    Endokrynol Pol; 2005; 56(1):4-5. PubMed ID: 16335666
    [No Abstract]   [Full Text] [Related]  

  • 7. Carcinoid of the pancreas.
    Migliori M; Tomassetti P; Lalli S; Casadei R; Santini D; Corinaldesi R; Gullo L
    Pancreatology; 2002; 2(2):163-6. PubMed ID: 12123097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Somatostatin analogs in the treatment of pancreatic cancer: utopia or feasible alternative?].
    Zalatnai A; Pogány V
    Orv Hetil; 2000 Oct; 141(43):2333-8. PubMed ID: 11089387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
    Shojamanesh H; Gibril F; Louie A; Ojeaburu JV; Bashir S; Abou-Saif A; Jensen RT
    Cancer; 2002 Jan; 94(2):331-43. PubMed ID: 11900219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
    Capello A; Krenning E; Bernard B; Reubi JC; Breeman W; de Jong M
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1288-95. PubMed ID: 16021448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Somatostatin receptors in meningioma: diagnostic and therapeutic value].
    Prat R; Banzo J; Díaz FJ
    Rev Neurol; 1997 Dec; 25(148):2002-5. PubMed ID: 9528047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
    Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Imaging of pediatric brain tumors using somatostatin analogue 111Ih-DTPA-D-Phe1-octreotide].
    Dabasi G; Hauser P; Kertész GP; Balázs G; Karádi Z; Constantin T; Bognár L; Klekner A; Schuler D; Garami M
    Magy Onkol; 2007; 51(3):229-34. PubMed ID: 17922063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes.
    Duncan JR; Stephenson MT; Wu HP; Anderson CJ
    Cancer Res; 1997 Feb; 57(4):659-71. PubMed ID: 9044843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and functional significance of somatostatin receptors in malignant melanoma.
    Lum SS; Fletcher WS; O'Dorisio MS; Nance RW; Pommier RF; Caprara M
    World J Surg; 2001 Apr; 25(4):407-12. PubMed ID: 11344389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indium-111-Octreotide scintigraphy in differentiated thyroid carcinoma metastases that do not respond to treatment with high-dose I-131.
    Stokkel MP; Reigman HI; Verkooijen RB; Smit JW
    J Cancer Res Clin Oncol; 2003 May; 129(5):287-94. PubMed ID: 12750997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin receptor scintigraphy before and after treatment with somatostatin analogues in patients with thyroid eye disease.
    Krassas GE; Doumas A; Kaltsas T; Halkias A; Pontikides N
    Thyroid; 1999 Jan; 9(1):47-52. PubMed ID: 10037076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor scintigraphy of a patient with a giant invasive prolactinoma.
    Meyer P; Bohnen NI; Barkan AL; Shapiro B
    Nuklearmedizin; 1999; 38(2):66-7. PubMed ID: 10100234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Somatostatin receptor scintigraphy in a patient with metastatic hemangiopericytoma].
    Müller V; Klutmann S; Clausen M
    Nuklearmedizin; 2003 Jun; 42(3):N13-4. PubMed ID: 12848152
    [No Abstract]   [Full Text] [Related]  

  • 20. Metastatic hormone-refractory prostatic adenocarcinoma expresses somatostatin receptors and is visualized in vivo by [111In]-labeled DTPA-D-[Phe1]-octreotide scintigraphy.
    Nilsson S; Reubi JC; Kalkner KM; Laissue JA; Horisberger U; Olerud C; Westlin JE
    Cancer Res; 1995 Dec; 55(23 Suppl):5805s-5810s. PubMed ID: 7493350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.